Peptides for Rheumatoid arthritis
The peptides people most often research for rheumatoid arthritis, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 7
- With human trials
- 2
- FDA approved (any use)
- 3
- SemaglutideGLP-1 agonistHuman RCT evidence, 4 of 4American heart journal 2025, PMID 40345413Human5Animal0Summarised2FDA approved (Ozempic, Wegovy, Rybelsus)For rheumatoid arthritisOverview
- TirzepatideGLP-1 / GIP dual agonistNo study with an outcome for rheumatoid arthritisPubMed search, 2 Oct 2026Human2Animal0Summarised1FDA approved (Mounjaro, Zepbound)For rheumatoid arthritisOverview
- KPVAnti-inflammatory tripeptideAnimal evidence, 2 of 4Inflammatory bowel diseases 2008, PMID 18092346Human1Animal0Summarised6PCAC voted 8–6 for 503A (Jul 2026)For rheumatoid arthritisOverview
- BPC-157Gastric pentadecapeptideAnimal evidence, 2 of 4Journal of physiology and pharmacology 2013, PMID 24304574Human1Animal0Summarised2PCAC voted 8–6 for 503A (Jul 2026)For rheumatoid arthritisOverview
- TB-500Synthetic fragment of thymosin beta-4Human RCT evidence, 4 of 4Microbial biotechnology 2021, PMID 34318587Human7Animal0Summarised2PCAC voted 8–6 for 503A (Jul 2026)For rheumatoid arthritisOverview
- HGHRecombinant growth hormoneNo study with an outcome for rheumatoid arthritisPubMed search, 2 Oct 2026Human12Animal1Summarised0FDA approved (prescription only)Overview
- IpamorelinGHRP (ghrelin receptor agonist)No study with an outcome for rheumatoid arthritisPubMed search, 11 Oct 2026Human0Animal0Summarised0Not FDA approved · research chemicalOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What rheumatoid arthritis is
MedlinePlus defines rheumatoid arthritis as a form of arthritis that causes pain, swelling and stiffness in the joints, and says it is an autoimmune disease.[33]
It says there is no cure for RA, but early treatment can help manage symptoms and reduce joint damage.[33]
What the listed peptides have been tested for
PubMed records matching the site's RA search (broad matches, not RA trials): Semaglutide 5 human-only and 0 animal-only; Tirzepatide 2 human-only and 0 animal-only; KPV 1 human-only and 0 animal-only; BPC-157 1 human-only and 0 animal-only; TB-500 7 human-only and 0 animal-only; growth hormone 12 human-only and 1 animal-only; Ipamorelin 0 human-only and 0 animal-only.
Calculated from goal rheumatoid-arthritis; ledger date 2026-10-02; counts semaglutide (human only 5, animal 0, rct 0), tirzepatide (human only 2, animal 0, rct 0), kpv (human only 1, animal 0, rct 0), bpc-157 (human only 1, animal 0, rct 0), tb-500 (human only 7, animal 0, rct 0), hgh (human only 12, animal 1, rct 0), ipamorelin (human only 0, animal 0, rct 0). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).
A trial in psoriatic arthritis, a different disease, found a greater ACR50 response with tirzepatide plus ixekizumab (33.5%) than with ixekizumab alone (20.4%), separating from week 4.[34]
The trial enrolled people with overweight or obesity, which the abstract says covers 72% to 82% of people with psoriatic arthritis; it does not test RA.[34]
Common questions
What is the best peptide for rheumatoid arthritis?
The site's ledger shows no randomized trial of these peptides in RA; the PubMed matches are broad search hits.
Calculated from goal rheumatoid-arthritis; counts semaglutide (human only 5, animal 0, rct 0), tirzepatide (human only 2, animal 0, rct 0), kpv (human only 1, animal 0, rct 0), bpc-157 (human only 1, animal 0, rct 0). Formula: Copied from goals.json for goal 'rheumatoid-arthritis': peptides[].ledger.humanOnly.n, ledger.animal.n and ledger.rct.n.
Is TB-500 or BPC-157 an RA treatment?
The ledger lists 7 human-only records for TB-500 and 1 for BPC-157 under RA; these are broad search matches, not arthritis trials.
Calculated from goal rheumatoid-arthritis; counts tb-500 (human only 7, animal 0, rct 0), bpc-157 (human only 1, animal 0, rct 0). Formula: Copied from goals.json for goal 'rheumatoid-arthritis': peptides[].ledger.humanOnly.n, ledger.animal.n and ledger.rct.n.
Explore nearby goals
Sources
- 1Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial.American heart journal · 2025PMID 40345413Accessed 2 Oct 2026
- 2Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
- 3Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
- 4Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.Microbial biotechnology · 2021PMID 34318587Accessed 2 Oct 2026
- 5PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 17PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 18PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 19PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 20PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt]) (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 21PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND ("growth hormone deficiency"[tiab]) AND adult*[tiab] AND randomized controlled trial[pt] (66 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 22PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (elderly[tiab] OR "older adults"[tiab] OR healthy[tiab]) AND (systematic review[pt] OR meta-analysis[pt]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 23PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (athlet*[tiab] OR "physical performance"[tiab] OR "recreational"[tiab]) AND (randomized controlled trial[pt] OR systematic review[pt]) (20 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 24PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND sleep[tiab] AND (randomized controlled trial[pt] OR clinical trial[pt]) (12 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 25PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (tendon[tiab] OR collagen[tiab] OR "wound healing"[tiab] OR fracture[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 26PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (cardiovascular[tiab] OR cardiac[tiab] OR "blood pressure"[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]) (77 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 27PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (diabetes[tiab] OR "insulin resistance"[tiab] OR glucose[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]) (52 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 28PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (skin[tiab] OR hair[tiab] OR aging[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (30 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 29PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND ("sexual function"[tiab] OR libido[tiab] OR "erectile"[tiab] OR "quality of life"[tiab]) AND adult*[tiab] AND (randomized controlled trial[pt] OR meta-analysis[pt]) (29 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 30PubMed search: ipamorelin[tiab] (50 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 31PubMed search: ipamorelin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 32PubMed search: ipamorelin[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 33Official web pageOfficial web page · web page
- 34Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.) · 2026PMID 41903163Accessed 2 Oct 2026
Found an error? Report a correction.